ArticleOncotarget2014

High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.

Yu-Jen Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.